These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 544418)

  • 21. High-performance liquid chromatography/atmospheric pressure chemical ionization mass spectrometric method for the analysis of catecholamines and metanephrines in human urine.
    Chan EC; Ho PC
    Rapid Commun Mass Spectrom; 2000; 14(21):1959-64. PubMed ID: 11085404
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Adrenergic system and stress].
    Klepping J; Escousse A; Didier JP
    Sem Hop; 1971 Jan; 47(2):116-32. PubMed ID: 4323176
    [No Abstract]   [Full Text] [Related]  

  • 23. [Increase of excretion of urinary catecholamines and its catabolites in a case of pulmonary sarcomatous tumor].
    Candito M; Bekri S; Monpoux P; Parisot F; Mariani R; Chambon P
    Pathol Biol (Paris); 1992 Dec; 40(10):1003-5. PubMed ID: 1299807
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Aerobic fitness and sympatho-adrenal response to short-term psycho-emotional stress under field conditions.
    Wittels P; Rosenmayr G; Bischof B; Hartter E; Haber P
    Eur J Appl Physiol Occup Physiol; 1994; 68(5):418-24. PubMed ID: 8076622
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Catecholamine measures for diagnosis and treatment of patients with depressive disorders.
    Schatzberg AF; Orsulak PJ; Rosenbaum AH; Kruger ER; Schildkraut JJ; Cole JO
    J Clin Psychiatry; 1980 Dec; 41(12 Pt 2):35-9. PubMed ID: 7440524
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Catecholamine measurements in pheochromocytoma and neuroblastoma.
    Spiegel HE
    Ann Clin Lab Sci; 1974; 4(3):174-7. PubMed ID: 4363482
    [No Abstract]   [Full Text] [Related]  

  • 27. Dopamine excess in patients with head and neck paragangliomas.
    Van Der Horst-Schrivers AN; Osinga TE; Kema IP; Van Der Laan BF; Dullaart RP
    Anticancer Res; 2010 Dec; 30(12):5153-8. PubMed ID: 21187504
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The effect of the activation of the sympathetic-adrenal system on the pulmonary inactivation of catecholamines in rats].
    Bonetskiĭ AA; Fedorov VI
    Fiziol Zh SSSR Im I M Sechenova; 1992 Feb; 78(2):81-6. PubMed ID: 1330737
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The use of an adrenalin test in evaluating the functional state of the sympathetic-adrenal system].
    Kassil' GN; Gugumiivili TsG; Zumler AS; Kolesov DV
    Biull Eksp Biol Med; 1969 Apr; 67(4):11-4. PubMed ID: 5785246
    [No Abstract]   [Full Text] [Related]  

  • 30. [The activity of the sympathoadrenal system during the adaptation process of the human organism to the living in the closed space].
    Larina IM; Bystritskaia AF; Davydova NA; Smirnova TM
    Fiziol Cheloveka; 2004; 30(1):105-16. PubMed ID: 15040293
    [No Abstract]   [Full Text] [Related]  

  • 31. Urinary epinephrine and norepinephrine levels in women athletes during training and competition.
    Pierce D; Kupprat I; Harry D
    Eur J Appl Physiol Occup Physiol; 1976 Dec; 36(1):1-6. PubMed ID: 1001312
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Problems of stress, adaptation and acute pathology in sports].
    Levando VA; Suzdal'nitskiĭ RS; Kassil' GN
    Vestn Akad Med Nauk SSSR; 1988; (4):82-90. PubMed ID: 3400314
    [No Abstract]   [Full Text] [Related]  

  • 33. Clinical studies on urinary metanephrine and normetanephrine in various endocrine diseases. 3. Clinical studies on urinary metanephrine and normetanephrine in the patients with diabetes mellitus and those with pituitary-adrenocortical and related diseases.
    Shimbo S
    Naika Hokan; 1968 Oct; 15(10):343-5. PubMed ID: 5751765
    [No Abstract]   [Full Text] [Related]  

  • 34. Catecholamine metabolism in Down's syndrome.
    Keele DK; Richards C; Brown J; Marshall J
    Am J Ment Defic; 1969 Jul; 74(1):125-9. PubMed ID: 4241489
    [No Abstract]   [Full Text] [Related]  

  • 35. VII. Long persisting changes in catecholamine metabolism following addiction to and withdrawal from morphine.
    Sloan JW; Eisenman AJ
    Res Publ Assoc Res Nerv Ment Dis; 1968; 46():96-105. PubMed ID: 5749392
    [No Abstract]   [Full Text] [Related]  

  • 36. Urinary catecholamines and their metabolites in diabetes.
    Abdel-Aziz MT; Abdel-Kader MM; Rashad MM
    Acta Biol Med Ger; 1975; 34?710():1643-50. PubMed ID: 788421
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Apropos of biological diagnosis of pheochromocytoma].
    Cier JF; Peyrin L
    Nouv Presse Med; 1978 May; 7(21):1863. PubMed ID: 673745
    [No Abstract]   [Full Text] [Related]  

  • 38. [Induced adrenalinuria test. I. Methods. Analysis of results].
    Fitoussi R; Mornex R; Peyrin L; Gibaud
    Rev Lyon Med; 1969; 18(14):525-8. PubMed ID: 5400683
    [No Abstract]   [Full Text] [Related]  

  • 39. [Catecholamine metabolism in the tissue of malignant and benign tumors of the sympathetic nervous system].
    Käser H; Türler K; Burri PH
    Schweiz Med Wochenschr; 1971 Apr; 101(13):484-7. PubMed ID: 5558918
    [No Abstract]   [Full Text] [Related]  

  • 40. A selective and sensitive assay for urinary metanephrine and normetanephrine using gas chromatography mass spectrometry with selected ion monitoring.
    Robertson D; Heath EC; Falkner FC; Hill RE; Brilis GM; Watson JT
    Biomed Mass Spectrom; 1978 Dec; 5(12):704-8. PubMed ID: 747744
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.